Belite Bio Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 02/17/2026 | 3.03 M | $486.92 M | 100.00% | 9.11% |
| RTW INVESTMENTS, LP | 02/17/2026 | 715.33 K | $114.42 M | 128.91% | 2.15% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 558.88 K | $89.40 M | 2,594.58% | 1.68% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 432.48 K | $69.18 M | -50.57% | 1.30% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 414.24 K | $66.26 M | 732.01% | 1.25% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 383.09 K | $61.28 M | 96.14% | 1.15% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 284.44 K | $45.50 M | 9,075.39% | 0.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 233.81 K | $37.40 M | 100.00% | 0.70% |
| MARSHALL WACE, LLP | 02/13/2026 | 192.70 K | $30.82 M | 2.77% | 0.58% |
| UBS GROUP AG | 01/29/2026 | 128.75 K | $20.60 M | 1,035.98% | 0.39% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 87.76 K | $14.04 M | 100.00% | 0.26% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 84.07 K | $13.45 M | 100.00% | 0.25% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 79.39 K | $12.70 M | 100.00% | 0.24% |
| WESTERN STANDARD LLC | 02/03/2026 | 60.03 K | $9.60 M | 100.00% | 0.18% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 44.60 K | $7.13 M | 1,103.43% | 0.13% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 40.35 K | $6.46 M | -80.78% | 0.12% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 39.84 K | $6.37 M | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 02/12/2026 | 32.32 K | $5.17 M | 100.00% | 0.10% |
| MORGAN STANLEY | 02/13/2026 | 28.01 K | $4.48 M | 435.62% | 0.08% |
| 02/17/2026 | 26.00 K | $4.16 M | 100.00% | 0.08% | |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 24.83 K | $3.97 M | 548.36% | 0.07% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 24.70 K | $3.95 M | 100.00% | 0.07% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 20.00 K | $3.20 M | 100.00% | 0.06% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 19.82 K | $3.17 M | 100.00% | 0.06% |
| WOODLINE PARTNERS LP | 02/17/2026 | 18.04 K | $2.89 M | 100.00% | 0.05% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 17.99 K | $2.88 M | 100.00% | 0.05% |
| STATE STREET CORP | 02/13/2026 | 15.74 K | $2.52 M | 18.59% | 0.05% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 15.54 K | $2.50 M | 100.00% | 0.05% |
| EXOME ASSET MANAGEMENT LLC | 02/13/2026 | 14.33 K | $2.29 M | 100.00% | 0.04% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 13.22 K | $2.11 M | 336.19% | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 11.90 K | $1.90 M | 100.00% | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 10.45 K | $1.67 M | -33.15% | 0.03% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 9.16 K | $1.47 M | 100.00% | 0.03% |
| 04/02/2026 | 9.16 K | $1.47 M | 100.00% | 0.03% | |
| HRT FINANCIAL LP | 02/12/2026 | 8.16 K | $1.31 M | 100.00% | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 6.20 K | $991.43 K | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 02/17/2026 | 5.06 K | $808.60 K | -53.31% | 0.02% |
| 02/12/2026 | 4.18 K | $669.27 K | 100.00% | 0.01% | |
| BARCLAYS PLC | 02/13/2026 | 4.18 K | $667.99 K | 100.00% | 0.01% |
| HIGH NET WORTH ADVISORY GROUP LLC | 01/23/2026 | 3.50 K | $559.86 K | 0.00% | 0.01% |
| 02/06/2026 | 3.44 K | $550.74 K | 100.00% | 0.01% | |
| Y-INTERCEPT (HONG KONG) LTD | 02/13/2026 | 3.15 K | $504.19 K | 100.00% | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 3.12 K | $498.92 K | 100.00% | 0.01% |
| ARROWPOINT INVESTMENT PARTNERS (SINGAPORE) PTE. LTD. | 02/11/2026 | 3.05 K | $487.72 K | 100.00% | 0.01% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 2.76 K | $441.00 K | 100.00% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 2.45 K | $391.58 K | -78.80% | 0.01% |
| YEOMANS CONSULTING GROUP, INC. | 01/07/2026 | 2.40 K | $383.74 K | 100.00% | 0.01% |
| CITIGROUP INC | 02/13/2026 | 2.14 K | $341.84 K | -46.71% | 0.01% |
| ROYAL BANK OF CANADA | 02/17/2026 | 2.09 K | $334.00 K | 100.00% | 0.01% |
| VIRTUS INVESTMENT ADVISERS, INC. | 02/17/2026 | 1.88 K | $301.05 K | 2.79% | 0.01% |
Belite Bio Inc institutional Ownership - FAQ's
During the previous two years, 80 institutional investors and hedge funds held shares of Belite Bio Inc. The most heavily invested institutionals were:
UBS Group AG: 768,359
TD ASSET MANAGEMENT INC: 33,410
BNP PARIBAS ARBITRAGE, SNC: 32,525
JANE STREET GROUP, LLC: 12,222
High Net Worth Advisory Group LLC: 3,500
Convergence Financial, LLC: 2,968
21.64% of Belite Bio Inc stock is owned by institutional investors.
Institutional investors have bought a total of 7.77 M shares in the last 24 months. This purchase volume represents approximately $1.39 B in transactions.